Researchers Urge: 'Prescribe Aspirin Based on Benefit-to-Risk Not Age'
Researchers provide a perspective on aspirin to prevent heart attacks and stroke and urge health care providers to make clinical judgements on a case-by-case basis and based on benefit-to-risk and not age.
·¬ÇÑÖ±²¥Study Reveals Gaps in Florida's COVID-19 Vaccine Rollout
Early distribution of COVID-19 vaccines in Florida reached the intended senior population, but it failed to ensure equal access for lower-income and minority communities, according to a new study.
Richard S. Isaacson, M.D., to Lead Alzheimer's Disease Prevention
A world-renowned clinician-researcher has joined the Schmidt College of Medicine to direct the ·¬ÇÑÖ±²¥Center for Brain Health to focus on Alzheimer's disease and neurodegenerative dementia prevention.
·¬ÇÑÖ±²¥Names New Dean of the Charles E. Schmidt College of Medicine
Julie G. Pilitsis, M.D., Ph.D., a leading neurosurgeon and physician scientist, will assume this role in February 2022.
Special Bond: Leading ·¬ÇÑÖ±²¥Geriatrician and World War II Hero
A leading geriatrician and advocate for seniors and a 98-year-old World War II veteran and hero have a common bond: to improve care and quality of life for Americans and people throughout the world.
·¬ÇÑÖ±²¥Expert on COVID-19 Boosters and Vaccines for Children Ages 5-11
Joanna Drowos, D.O., M.P.H., M.B.A., ·¬ÇÑÖ±²¥Schmidt College of Medicine, provides answers to some of the most frequently asked questions regarding the COVID-19 boosters and vaccines for children ages 5 to 11.
FAU's Schmidt College of Medicine Receives $1 Million Gift
·¬ÇÑÖ±²¥'s Charles E. Schmidt College of Medicine has received a $1 million gift from Norton and Anita Waltuch to provide support for medical student scholarships.
EMS Ketamine Use on Patients on Cocaine Raises Intubation 5.75-fold
·¬ÇÑÖ±²¥Schmidt College of Medicine researchers explored the sedative used by EMS for 'excited delirium,' a form of aggressive behavior, and the effects of illicit substances on ensuing hospital intubations.
'Stop Prescribing Hydroxychloroquine for COVID-19'
Schmidt College of Medicine researchers reviewed the recent major randomized, double-blind placebo-controlled trials for hydroxychloroquine, finding a lack of significant benefit and some suggestion of harm.
Genomic Surveillance Crucial to Mitigate and Contain COVID-19
Researchers say that genomic surveillance to mitigate and contain COVID-19 is crucial to detect variants that are different well before they spread throughout the U.S. and the rest of the world.